Razenberg, L. G. E. M., van Gestel, Y. R. B. M., de Hingh, I. H. J. T., Loosveld, O. J. L., Vreugdenhil, G., Beerepoot, L. V., . . . Lemmens, V. E. P. P. (2016). Bevacizumab for metachronous metastatic colorectal cancer: A reflection of community based practice. BMC Cancer.
Chicago Style CitationRazenberg, L. G. E. M., Y. R. B. M. van Gestel, I. H. J. T. de Hingh, O. J. L. Loosveld, G. Vreugdenhil, L. V. Beerepoot, G. J. Creemers, i V. E. P. P. Lemmens. "Bevacizumab for Metachronous Metastatic Colorectal Cancer: A Reflection of Community Based Practice." BMC Cancer 2016.
Cita MLARazenberg, L. G. E. M., et al. "Bevacizumab for Metachronous Metastatic Colorectal Cancer: A Reflection of Community Based Practice." BMC Cancer 2016.
Atenció: Aquestes cites poden no estar 100% correctes.